| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system.
|
J Rheumatol
|
2003
|
3.61
|
|
2
|
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Exercise 3: an international multicenter reliability study using the RA-MRI Score.
|
J Rheumatol
|
2003
|
2.04
|
|
3
|
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Exercise 4: an international multicenter longitudinal study using the RA-MRI Score.
|
J Rheumatol
|
2003
|
1.65
|
|
4
|
A comparison of magnetic resonance imaging, sonography, and radiography of the hand in patients with early rheumatoid arthritis.
|
J Rheumatol
|
2004
|
1.55
|
|
5
|
Synovitis and osteitis are very frequent in rheumatoid arthritis clinical remission: results from an MRI study of 294 patients in clinical remission or low disease activity state.
|
J Rheumatol
|
2011
|
1.27
|
|
6
|
Determining a magnetic resonance imaging inflammatory activity acceptable state without subsequent radiographic progression in rheumatoid arthritis: results from a followup MRI study of 254 patients in clinical remission or low disease activity.
|
J Rheumatol
|
2013
|
1.15
|
|
7
|
OMERACT Rheumatoid Arthritis Magnetic Resonance Imaging Studies. Summary of OMERACT 6 MR Imaging Module.
|
J Rheumatol
|
2003
|
1.07
|
|
8
|
The role of MRI in rheumatoid arthritis: research and clinical issues.
|
Curr Opin Rheumatol
|
2009
|
1.02
|
|
9
|
Structure-activity relationships of 3-aminoquinazolinediones, a new class of bacterial type-2 topoisomerase (DNA gyrase and topo IV) inhibitors.
|
Bioorg Med Chem Lett
|
2006
|
1.01
|
|
10
|
The OMERACT psoriatic arthritis magnetic resonance imaging scoring system (PsAMRIS): definitions of key pathologies, suggested MRI sequences, and preliminary scoring system for PsA Hands.
|
J Rheumatol
|
2009
|
1.00
|
|
11
|
Reducing invasiveness, duration, and cost of magnetic resonance imaging in rheumatoid arthritis by omitting intravenous contrast injection -- Does it change the assessment of inflammatory and destructive joint changes by the OMERACT RAMRIS?
|
J Rheumatol
|
2009
|
1.00
|
|
12
|
A multi-center, observational study shows high proportion of Australian rheumatoid arthritis patients have inadequate disease control.
|
Int J Rheum Dis
|
2013
|
0.94
|
|
13
|
The evidence for magnetic resonance imaging as an outcome measure in proof-of-concept rheumatoid arthritis studies.
|
J Rheumatol
|
2005
|
0.94
|
|
14
|
Development and preliminary validation of a magnetic resonance imaging joint space narrowing score for use in rheumatoid arthritis: potential adjunct to the OMERACT RA MRI scoring system.
|
J Rheumatol
|
2011
|
0.94
|
|
15
|
Barriers to optimal disease control for rheumatoid arthritis patients with moderate and high disease activity.
|
Arthritis Care Res (Hoboken)
|
2014
|
0.93
|
|
16
|
Magnetic resonance imaging in rheumatoid arthritis advances and research priorities.
|
J Rheumatol
|
2005
|
0.87
|
|
17
|
Iterative development and reliability of the OMERACT hand osteoarthritis MRI scoring system.
|
J Rheumatol
|
2013
|
0.86
|
|
18
|
Developing a magnetic resonance imaging scoring system for peripheral psoriatic arthritis.
|
J Rheumatol
|
2007
|
0.84
|
|
19
|
A multicenter reliability study of extremity-magnetic resonance imaging in the longitudinal evaluation of rheumatoid arthritis.
|
J Rheumatol
|
2007
|
0.83
|
|
20
|
OMERACT Rheumatoid Arthritis MRI Studies Module.
|
J Rheumatol
|
2003
|
0.81
|
|
21
|
The OMERACT-RAMRIS rheumatoid arthritis magnetic resonance imaging joint space narrowing score: intrareader and interreader reliability and agreement with computed tomography and conventional radiography.
|
J Rheumatol
|
2013
|
0.80
|
|
22
|
No overall damage progression despite persistent inflammation in adalimumab-treated psoriatic arthritis patients: results from an investigator-initiated 48-week comparative magnetic resonance imaging, computed tomography and radiography trial.
|
Rheumatology (Oxford)
|
2013
|
0.79
|
|
23
|
Testing an OMERACT MRI scoring system for peripheral psoriatic arthritis in cross-sectional and longitudinal settings.
|
J Rheumatol
|
2009
|
0.78
|
|
24
|
Update on the OMERACT magnetic resonance imaging task force: research and future directions.
|
J Rheumatol
|
2013
|
0.77
|
|
25
|
How well do patients understand written instructions?: health literacy assessment in rural and urban rheumatology outpatients.
|
Medicine (Baltimore)
|
2014
|
0.76
|
|
26
|
The OMERACT Magnetic Resonance Imaging Inflammatory Arthritis Group - advances and priorities.
|
J Rheumatol
|
2007
|
0.76
|
|
27
|
The OMERACT MRI inflammatory arthritis group: advances and future research priorities.
|
J Rheumatol
|
2009
|
0.76
|
|
28
|
Update on research and future directions of the OMERACT MRI inflammatory arthritis group.
|
J Rheumatol
|
2011
|
0.76
|
|
29
|
The OMERACT Psoriatic Arthritis Magnetic Resonance Imaging Score (PsAMRIS) is reliable and sensitive to change: results from an OMERACT workshop.
|
J Rheumatol
|
2011
|
0.76
|
|
30
|
Magnetic resonance imaging computerized assessment in rheumatoid arthritis: comment on the article by Goldbach-Mansky et al.
|
Arthritis Rheum
|
2004
|
0.75
|
|
31
|
Australian and New Zealand national evidence-based recommendations for the investigation and follow-up of undifferentiated peripheral inflammatory arthritis: an integration of systematic literature research and rheumatological expert opinion.
|
Int J Rheum Dis
|
2013
|
0.75
|
|
32
|
Consensus statement on the investigation and management of non-radiographic axial spondyloarthritis (nr-axSpA).
|
Int J Rheum Dis
|
2014
|
0.75
|
|
33
|
Reliability and longitudinal validity of computer-assisted methods for measuring joint damage progression in subjects with rheumatoid arthritis.
|
J Rheumatol
|
2012
|
0.75
|
|
34
|
Ultrasound versus high field magnetic resonance imaging in rheumatoid arthritis.
|
Clin Exp Rheumatol
|
2014
|
0.75
|